Intelligent Bio Solutions (INBS) Income from Non-Controlling Interests (2019 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Income from Non-Controlling Interests of -$7148.0 in Q1 2025, up 2.44% quarter-over-quarter from -$7327.0 in Q4 2024, and up 21.43% on a YoY basis from -$5886.4 in Q1 2024.
Intelligent Bio Solutions (INBS) Income from Non-Controlling Interests (2019 - 2025) Analysis & Trends
Intelligent Bio Solutions' Income from Non-Controlling Interests history runs 7 years deep, the most recent figure standing at -$7148.0 for Q1 2025.
- In Q1 2025, Income from Non-Controlling Interests rose 21.43% year-over-year to -$7148.0; the TTM figure through Mar 2025 stood at -$32739.0 (up 7.85% YoY), while the FY2023 annual figure was -$32835.0, down 17.58% from the prior year.
- Income from Non-Controlling Interests was -$7148.0 for Q1 2025 at Intelligent Bio Solutions, up from -$7327.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $2769.0 in Q2 2021 to a low of -$14854.0 in Q1 2021.
- Historically, Income from Non-Controlling Interests has averaged -$7471.6 across 5 years, with a median of -$7273.5 in 2023.
- Biggest YoY gain for Income from Non-Controlling Interests was 139.76% in 2021; the steepest drop was 1100.27% in 2021.
- A 5-year view of Income from Non-Controlling Interests shows it stood at -$3825.0 in 2021, then sank by 69.18% to -$6471.0 in 2022, then decreased by 4.19% to -$6742.0 in 2023, then dropped by 8.68% to -$7327.0 in 2024, then climbed by 2.44% to -$7148.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at -$7148.0 (Q1 2025), -$7327.0 (Q4 2024), and -$9166.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -7,148.00 |
| Dec 31, 2024 | -7,327.00 |
| Sep 30, 2024 | -9,166.00 |
| Mar 31, 2024 | -9,098.00 |
| Dec 31, 2023 | -6,742.00 |
| Sep 30, 2023 | -7,220.00 |
| Jun 30, 2023 | -12,468.00 |
| Mar 31, 2023 | -8,111.00 |
| Dec 31, 2022 | -6,471.00 |
| Sep 30, 2022 | -5,785.00 |
| Jun 30, 2022 | -10,025.00 |
| Mar 31, 2022 | -8,887.00 |
| Dec 31, 2021 | -3,825.00 |
| Sep 30, 2021 | -5,188.00 |
| Jun 30, 2021 | 2,769.00 |
| Mar 31, 2021 | -14,854.00 |
| Dec 31, 2020 | -6,425.00 |
| Sep 30, 2020 | -4,405.00 |
| Jun 30, 2020 | -6,964.00 |
| Mar 31, 2020 | 1,485.00 |